Analogue engineering still relies heavily on manual intervention, but that is changing with the growing use of AI/ML.

User simulators serve two critical roles when integrated with interactive AI systems: they enable evaluation via repeatable, ...

As a drug moves through research and regulatory processes, any mistakes in the data will be compounded. Small gaps that a ...

Check out this new research in Engineering! It introduces an adaptive edge-cloud collaboration method for intelligent machine ...

The UltiSim Data Fusion Plane solves this challenge by allowing mid-market organizations to connect, transform, and access disparate and siloed data across the enterprise for AI applications -- ...

Bapco Energies is Bahrain's integrated energy company, driving the Kingdom's energy transition by managing and optimizing resources across upstream, downstream, and renewable portfolios. Bapco ...

A new suite of tools and services address need for high-quality domain-specific datasets and human feedback pipelines ...

Drug resistance remains a central barrier to durable responses across cancer therapies, spanning targeted agents, cytotoxic chemotherapy, endocrine ...

Understanding how these new capabilities are emerging across nuclear can help leaders position themselves for the next phase ...

In his keynote address, Prof. Sastry emphasized that AI is dramatically accelerating drug discovery timelines, reducing costs, and enabling precision-driven research outcomes.

As we step into 2026, the AI and analytics story for health care and life sciences isn’t about sudden disruption – it’s about ...